So, Quizartinib is this FLT3 inhibitor that’s been approved to help with AML that doesn’t respond to treatment, especially when there’s this FLT3-ITD thing going on. Well, it works by blocking this FLT3 signaling thing, which is kind of a big deal in how AML starts up. You can get the drug in two doses—17.7 milligrams and 26.5 milligrams—and they’re both these coated tablets.
The usual starting dose is 53 mg taken once every day, after starting with a lower dose. These tablets come in bottles with 28 of ’em in each one.
